About US
Contact us
-
Bristol Myers Squibb takes on racial inequality with $300M pledge to up diversity, improve healthcare accessThe recent death of George Floyd hasset off a broad discussion around racism and the different forms of inequalitypeople of color experience in the U.S. One of the disparities lies in healthcare, and2020/8/13
-
After nearly $1B in research funding, Moderna takes $1.5B coronavirus vaccine order from U.S.Through its COVID-19 vaccine partnership with the U.S. government, Moderna picked up nearly $1 billion in research aid. Now, it's joining a list of other companies to take a supplyorder from the fede2020/8/13
-
Mesoblast faces FDA pushback over cell therapy manufacturing, clinical data: documentsThe FDA in recent years has been tough on cell and gene therapy makers, particularly when its comes to approving thelabor-intensive and complicated manufacturing process. The agency now has its eyes2020/8/12
-
AstraZeneca bumps up vaccine deal with Brazil to $360M with more doses, licensing rightsIn an effort to supercharge distribution of its vaccine hopeful, British drugmaker AstraZeneca has spanned the globe to ink a slew of national supply deals. Now, after striking a more limited pact in2020/8/12
-
Novavax aims for billions of COVID-19 vaccine doses in 2021—more than enough to supply U.S.Some of the world’s largest biopharma companies are working to deliversafe and effectiveCOVID-19 vaccines, butat the same time, a much smallerbiotech has laid out its own big ambitions in the field.2020/8/11
-
Russia skips ahead in COVID vaccine race, triggering outcry over unproven 'Sputnik V' shotAs globalvaccine players rush to deliver COVID-19 vaccines, Russia shocked the world Tuesday with newsthatit had approved a locally developedinoculation. But that approval was based on skimpy data, a2020/8/11
-
Eisai will shift U.S. HQ to New Jersey 'bio-ecosystem' in move to boost oncology, neurology portfoliosJapanese drugmaker Eisai has established asolid foothold in the U.S. market and found some success with its Merck & Co.-partnered oncology med Lenvima. And alongside BIogen, it's in the FDA queue2020/8/10
-
Coronavirus tracker: Sinovac unveils midstage vaccine data; Daewoong OK'd to test tapeworm med against virusChina's Sinovac kicked off a coronavirusvaccine trial in Indonesia and revealed promising data on its candidate from a mid-stage study. South Korea's Daewoong Pharmaceutical got a thumbs up to test a2020/8/10
-
Amid COVID deal spree, Catalent plots Argentina manufacturing scale-upAmid a slew of COVID-19 vaccine pacts, Catalent is looking to expand its manufacturing power to churn out more drugsfor a wholly different set of diseases. Set to go live in late2021, a revamped site2020/8/7
-
AstraZeneca takes COVID-19 vaccine to China with BioKangtai deal for 200M-dose capacity by 2021We pointed out last week that China was a notablemissing elementin AstraZeneca’s COVID-19 vaccine strategy, despite being the drugmaker’s second-largest market. That has changed. AstraZenecareached a2020/8/6